Aporphine derivatives and pharmaceutical use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 10, 2012
Grant Date -
Dec 24, 2009
app pub date -
Jun 19, 2009
filing date -
Jun 20, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention discloses novel aporphine derivatives. Also, the present invention discloses that these novel aporphine derivatives can be used for treating oxidative stress induced diseases such as cardiovascular disease, diabetes, aging, Alzheimer's disease, kidney disease, cancer or brain ischemic disease etc.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully